Exhibit 99.1

ACCELRYS ANNOUNCES THIRD QUARTER FISCAL YEAR 2010

FINANCIAL RESULTS

Revenue up 7% over previous year

SAN DIEGO, California, February 4, 2010 — Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the quarter ended December 31, 2009. Revenue for the quarter increased 7% to $22.1 million from $20.6 million for the same quarter of the previous year. Revenue for the nine months ended December 31, 2009 increased 2% to $62.2 million from $61.0 million for the same period of the previous year.

Non-GAAP net income was $2.1 million, or $0.08 per diluted share, for the current quarter compared to non-GAAP net income of $2.5 million, or $0.09 per diluted share, for the same quarter of the previous year. Non-GAAP net income was $7.2 million, or $0.26 per diluted share, for the nine months ended December 31, 2009 compared to non-GAAP net income of $7.4 million, or $0.27 per diluted share, for the same period of the previous year.

GAAP net income was $1.0 million, or $0.04 per diluted share, for both the current quarter and the same quarter of the previous year. GAAP net income was $3.6 million, or $0.13 per diluted share, for the nine months ended December 31, 2009 compared to GAAP net income of $2.3 million, or $0.09 per diluted share, for the same period of the previous year.

The Company’s balance sheet as of December 31, 2009 included cash, cash equivalents, marketable securities and restricted cash of $77.6 million. Deferred revenue at the end of the third quarter was $56.9 million. The Company has no debt outstanding.

“This was a good quarter with solid increase in revenue growth and a sound performance across the business in this our traditionally biggest period,” said Max Carnecchia, President and CEO, Accelrys, Inc. “Our software and services businesses performed well in spite of continuing soft economic conditions, with customers showing continuing support for our leading solutions. We look forward to welcoming many of them to our Global User Group meeting in Boston, May 4-6, 2010.”

Other highlights for the quarter included:

 

   

A strong performance in our Materials business;

 

   

A highly successful launch of Materials Studio 5.0, our flagship materials modeling and simulation product; and

 

   

The appointment of two senior executives, with the arrival of software veterans Michael Piraino as the new Chief Financial Officer, and Paul Burrin as Chief Marketing Officer.

Q3 Fiscal Year 2010 Conference Call

Accelrys will conduct a conference call to discuss its financial results at 5:00 p.m. ET, February 4, 2010. To participate, please dial (866) 393-7459 (+1 (706) 643-4624 outside the United States) and enter the access code, 51743050, approximately 15 minutes before the scheduled start of the call. The conference call will also be accessible live on the Investor Relations section of the Accelrys website at www.accelrys.com.

A replay of the conference call will be available online at www.accelrys.com and via telephone by dialing (800) 642-1687 (+1 (706) 645-9291 outside the United States) and entering access code, 51743050, beginning 8:00 p.m. ET on February 4, 2010 through 11:59 p.m. ET on March 4, 2010.

 

1


Non-GAAP Financial Measures

This press release describes financial measures for operating income, net income, and net income per diluted share that exclude share-based compensation expense, purchased intangible assets amortization and restructuring charges (recoveries). These financial measures are not calculated in accordance with generally accepted accounting principles (GAAP) and are not based on any comprehensive set of accounting rules or principles.

Management believes these non-GAAP financial measures provide a useful measure of the Company’s operating results, a meaningful comparison with historical results and with the results of other companies, and insight into the Company’s ongoing operating performance. Further, management and the Board of Directors utilize these measures, in addition to GAAP measures, when evaluating and comparing the Company’s operating performance against internal financial forecasts and budgets. These non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. In addition, these non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

For additional information on the items excluded by the Company from its non-GAAP financial measures please refer to the Form 8-K regarding this release that was furnished today to the Securities and Exchange Commission.

The following table contains a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures (unaudited, amounts in thousands, including footnotes):

 

     Three Months Ended
December 31,
   Nine Months Ended
December 31,
     2009     2008    2009     2008

GAAP Operating income

   $ 1,122      $ 764    $ 4,046      $ 2,184

Share-based compensation expense1

     1,107        1,119      2,916        3,112

Purchased intangible asset amortization2

     41        381      803        1,143

Restructuring charges (recoveries)3

     (16     —        (90     850
                             

Non-GAAP Operating income

   $ 2,254      $ 2,264    $ 7,675      $ 7,289
                             

GAAP Net income

   $ 979      $ 1,010    $ 3,569      $ 2,323

Share-based compensation expense

     1,107        1,119      2,916        3,112

Purchased intangible asset amortization

     41        381      803        1,143

Restructuring charges (recoveries)3

     (16     —        (90     850
                             

Non-GAAP Net income

   $ 2,111      $ 2,510    $ 7,198      $ 7,428
                             

GAAP Diluted net income per share

   $ 0.04      $ 0.04    $ 0.13      $ 0.09

Share-based compensation expense

     0.04        0.04      0.11        0.11

Purchased intangible asset amortization

     —          0.01      0.03        0.04

Restructuring charges (recoveries)3

     —          —        —          0.03
                             

Non-GAAP Diluted net income per share4

   $ 0.08      $ 0.09    $ 0.26      $ 0.27
                             

 

1

Share-based compensation expense is included in our condensed consolidated statements of operations as follows:

 

     Three Months Ended
December 31,
   Nine Months Ended
December 31,
     2009    2008    2009    2008

Cost of revenue

   $ 86    $ 106    $ 198    $ 310

Product development

     253      255      704      731

Sales and marketing

     305      342      763      810

General and administrative

     463      416      1,251      1,261
                           

Total share-based compensation expense

   $ 1,107    $ 1,119    $ 2,916    $ 3,112
                           

 

2

Purchased intangible asset amortization is included in the cost of revenue line in our condensed consolidated statements of operations.

3

Restructuring charges (recoveries) are included in the restructuring charges (recoveries) line in our condensed consolidated statements of operations.

4

Earnings per share amounts for the nine months ended December 31, 2009 do not add due to rounding.

 

2


About Accelrys

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Our customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. We have a vast portfolio of computer-aided design modeling and simulation offerings which assist our customers in conducting scientific experiments ‘in silico’ in order to reduce the duration and cost of discovering and developing new drugs and materials. Our scientific business intelligence platform underlies most of our computer-aided design modeling and simulation offerings. Our platform can be used with our products, our competitors’ products and our customers’ proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable our customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, please visit our website at http://www.accelrys.com.

Forward-Looking Statements

Statements contained in this press release relating to the Company’s or management’s intentions, hopes, beliefs, expectations or predictions of the future are forward-looking statements. Such forward-looking statements including, but not limited to, statements relating to the Company’s products and prospects are subject to a number of risks and uncertainties. These include risks that the Company will not achieve its anticipated results due to, among other possibilities, an inability to withstand negative conditions in the global economy or a lack of demand for or market acceptance of the Company’s products, as well as the risks and uncertainties that are contained from time to time in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Annual Report on Form 10-K for the year ended March 31, 2009, quarterly reports on Form 10-Q and current reports on Form 8-K. The Company’s actual results could differ materially from those projected in such forward-looking statements due to these risks and uncertainties, and the Company disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future events or otherwise.

Contacts

Accelrys, Inc.

Michael A. Piraino

Senior Vice President and Chief Financial Officer

858-799-5200

Investor Relations

MKR Group

Charles Messman or Todd Kehrli

323-468-2300

accl@mkr-group.com

 

3


ACCELRYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended
December 31,
   Nine Months Ended
December 31,
     2009     2008    2009     2008

Revenue

   $ 22,071      $ 20,609    $ 62,200      $ 61,021

Cost of revenue

     4,096        4,385      10,896        11,390
                             

Gross margin

     17,975        16,224      51,304        49,631

Operating expenses:

         

Product development

     3,526        3,440      10,980        11,550

Sales and marketing

     9,387        8, 815      25,342        25,122

General and administrative

     3,956        3,205      11,026        9,925

Restructuring charges (recoveries)

     (16     —        (90     850
                             

Total operating expenses

     16,853        15,460      47,258        47,447
                             

Operating income

     1,122        764      4,046        2,184

Interest and other income, net

     352        423      620        1,046
                             

Income before taxes

     1,474        1,187      4,666        3,230

Income tax expense

     495        177      1,097        907
                             

Net income

     979        1,010      3,569        2,323
                             

Basic and diluted net income per share

   $ 0.04      $ 0.04    $ 0.13      $ 0.09
                             

Weighted average shares used to compute basic and diluted net income per share

         

Basic

     27,602        27,145      27,470        27,049

Diluted

     27,788        27,186      27,704        27,186

 

4


ACCELRYS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     December 31,
2009
   March 31,
2009
     (Unaudited)    (Audited)

Assets

     

Cash, cash equivalents, and marketable securities1

   $ 77,596    $ 81,769

Trade receivables, net

     31,619      21,860

Other assets, net2

     55,555      56,985
             

Total assets

   $ 164,770    $ 160,614
             

Liabilities and stockholders’ equity

     

Current liabilities, excluding deferred revenue

     14,016      15,427

Total deferred revenue3

     56,896      57,224

Noncurrent liabilities, excluding deferred revenue

     7,213      7,204

Total stockholders’ equity

     86,645      80,759
             

Total liabilities and stockholders’ equity

   $ 164,770    $ 160,614
             

 

1

Cash, cash equivalents, and marketable securities consist of the following line items in our consolidated balance sheet: Cash and cash equivalents; Marketable securities; Marketable securities, net of current portion; and Restricted cash

2

Other assets, net, consists of the following line items in our consolidated balance sheet: Prepaid expenses, deferred tax assets and other current assets; Property and equipment, net; Goodwill; Purchased intangible assets, net; and Other assets

3

Total deferred revenue consists of the following line items in our consolidated balance sheet: Current portion of deferred revenue; and Deferred revenue, net of current portion

 

5